Definitive Contract 75A50424C00002

Award Date 11/1/23
Potential Completion Date 9/26/26
Potential Value $88M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77002, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $144,763,969 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Safesource Direct LLC for the industrial base expansion of nitrile butadiene rubber (NBR). The contract is not set aside. The contract stems from a Commercial Solutions Opening (CSO) solicitation issued by the Department of the Air Force Acquisition COVID-19 Task Force to support the Department of Health and Human Services' Strategic...
This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Anatrace Products, LLC (doing business as Calibre Scientific), a for-profit organization. The $11,491,300.00 firm fixed-price contract is to procure additional equipment and capacity to support the production ramp up, as well as ancillary services, in order to expand the United States' personal protective equipment (PPE) production capability. The contract does not...
This is a Definitive Contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Labcon, North America, a division of Helena Laboratories Corporation. The $4,912,008 Firm Fixed Price contract is for COVID-19 industrial base expansion, transitioning from a prior $59.3 million Department of the Air Force contract. The award does not have a set-aside designation. The original...
This is a $69,300,000.00 firm-fixed-price definitive contract awarded by the Aeronautical Systems Center, a defense agency, to Continuus Pharmaceuticals, Inc. for the COVID-19 DHHS capacity expansion to provide integrated continuous manufacturing of three COVID-related pharmaceuticals. The contract will result in the capacity to produce 100 million doses per year of these COVID-related pharmaceuticals. There was no set-aside used for this contract, and the ultimate completion date is June 12,...
This federal contract award is an Other Transaction Agreement between Global Life Sciences Solutions USA LLC and the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The $72,104,359.91 cost-sharing agreement is focused on expanding capacity for COVID-19 response and supporting public health emergencies, with a completion date of December 31, 2038. Global Life Sciences Solutions USA LLC, a for-profit limited liability company and wholly owned subsidiary...
This is a $19,344,395.66 firm fixed price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Apiject Systems America, Inc. The contract is for the delivery of COVID-19 injector sets, transitioning an existing Department of Defense (DOD)/Air Force (AF) procurement to HHS/ASPR. The contract has no set-aside designation and runs through December 31, 2025. Apiject Systems...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...
This is a $190,241,861.21 Other Transaction Agreement awarded by the Department of the Army's Joint PEO Chemical and Biological Defense to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company. The contract does not have a set-aside designation. The agreement, awarded on February 21, 2020, supports the development and manufacturing of medical countermeasures against biological threats and COVID-19. Resilience has provided...
This contract award is for the delivery of Pfizer COVID-19 vaccines in support of the U.S. government's pandemic response efforts. The $2,162.70 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a completion date of February 22, 2024 and does not utilize any set-aside designations. Amerisourcebergen...
This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal...

This is a $87,666,337.42 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Ascend Performance Materials Texas Inc. for the domestic industrial base expansion of key chemicals for acrylonitrile butadiene rubber (NBR). The contract has an ultimate completion date of September 26, 2026. This award was made under a Commercial Solutions Opening solicitation that sought proposals to support the Department of Health and Human Services' Strategic National Stockpile goals and the Department of the Air Force Acquisition COVID-19 Task Force mission, with a focus on expanding domestic manufacturing capacity for personal protective equipment, medical supplies, pharmaceuticals, and vaccines in response to the COVID-19 pandemic. The contract does not have a set-aside designation.

Generated 3/26/25, 9:46 AM